Table 1 Patient characteristics
Characteristic | Patients |
|---|---|
n (%) | |
Age, years | |
Median | 55 |
Range | 24–77 |
Sex | |
Male | 10 (50) |
Female | 10 (50) |
Histology | |
PTCL-NOS | 10 (50) |
AITL | 9 (45) |
ALCL, ALK negative | 1 (5) |
Stage at enrolment | |
I–II | 1 (5) |
III–IV | 19 (95) |
Extranodal involvement | 10 (50) |
International Prognostic Index | |
≥2 | 16 (80) |
No. of prior regimens | |
Median | 2 |
Range | 1–4 |
Refractory to most recent therapy | 12 (60) |